The role of anti-mullerian hormone in determining ovarian reserve in patients with endometrioma and benign cysts

In: Zeynep Kamil Medical Journal · 2024 · pp. 29–33 · doi:10.14744/zkmj.2023.71084 · W4392824117
OA: bronze CC0
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This study measured pre- and postoperative Anti-Mullerian Hormone (AMH) levels to assess endometrioma's effect on ovarian reserve in patients with endometrioma and benign cysts.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Objective: Our aim was to determine the effects of endometrioma by itself and its surgery on ovarian reserve via pre-and postoperative serial measurements of Anti-Mullerian Hormone (AMH) in patients with endometrioma and benign cysts.

My notes (saved in your browser only)

Condition tags

endometrioma

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (12)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK